Clover Health Investments, Corp. (CLOV) company profile
Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –
About Clover Health Investments
Hospital & Medical Service Plans, SIC 6324
Clover Health operates as a healthcare technology and insurance company focused on empowering physicians with proprietary software to detect, manage, and treat chronic conditions. Its primary insurance offerings include Medicare Advantage Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans, alongside specialized programs like Clover Home Care for complex patients. The company also offers Counterpart Assistant, a clinician-centric software-as-a-service and technology-enabled platform licensed to external payors and providers. Clover Health primarily serves Medicare-eligible beneficiaries, particularly seniors with chronic diseases and individuals residing in historically underserved communities.
As of January 1, 2026, the company operates its Medicare Advantage plans across five states and 203 counties. As of December 31, 2025, Clover Health employs 724 individuals located primarily in the United States and Hong Kong. Operating under a remote-first organizational model, Clover Health does not maintain a corporate headquarters.
Summary of the business section of Clover Health Investments's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Clover Health Investments, Corp.
- Founded
- 2019
- Headquarters
- Jersey City, NJ
- Address
- 30 Montgomery Street 07302
- Phone
- (201) 432-2133
- Website
- cloverhealth.com
- Employees
- 724, Dec 31, 2025
- Industry
- Hospital & Medical Service Plans
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, New York, New York
Stock & identifiers
- Ticker
- CLOV
- Former tickers
- IPOC until Mar 31, 2021
- Exchange
- Nasdaq
- IPO date
- Apr 23, 2020
- Shares outstanding
- 531M, Jul 31, 2026
- Public float
- $1.13B, Jun 30, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 19-for-3, May 17, 2021
- SEC CIK
- 1801170
- CUSIP
- 18914F103
- ISIN
- US18914F1030
- FIGI
- BBG00SHY90J5
- Share class FIGI
- BBG00SHY90K3
- LEI
- 5493000HLYOYQU6LK133
- EIN
- 98-1515192
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Andrew Toy | Chief Executive Officer, Director | 9,078,334 |
| Joseph Frank Oldakowski | Chief Accounting Officer | 462,300 |
| Joseph Clay Thornton | Chief Financial Officer | 1,573,882 |
| Jamie L. Reynoso | CEO, Medicare Advantage | 2,770,351 |
| Karen Soares | Chief Legal Officer | 1,573,423 |
| Conrad Wai | CEO, Counterpart Health | 2,212,128 |
| Brady Patrick Priest | CEO of Clover Care Services | 2,040,222 |
| Peter J. Kuipers | Chief Financial Officer | 5,758,353 |
| Robert G. Torricelli | Director | 186,897 |
| Brian James Miller | Director | 12,481 |
| Carladenise Armbrister Edwards | Director | 285,432 |
| Vivek Garipalli | Director | 95,687,832 |
| Thomas L. Tran | Director | 180,029 |
| William G. Robinson Jr | Director | 597,987 |
| Demetrios L. Kouzoukas | Director | 605,980 |
| Anna U. Loengard | Director | 584,666 |
| Lee Shapiro | Director | 598,622 |
| Chelsea Clinton | Director | 602,814 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $1.32M | -$3.08M | $1.48M | $15 | $96 |
| FY2024 | $9.48M | $23.94M | $3.29M | $20 | $78 |
| FY2023 | $10.15M | $10.67M | $1.68M | $6 | $79 |
| FY2022 | $0 | -$39.38M | $9.28M | $6 | $74 |
| FY2021 | $389.57M | $62.37M | $37.03M | $23 | $93 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Andrew Toy Co-Founder and Chief Executive Officer | $800.00K | – | $509.54K | $9.85K | $1.32M | -86% |
| Peter Kuipers Chief Financial Officer | $525.00K | $1.18M | $344.14K | – | $2.05M | -59% |
| Jamie L. Reynoso Chief Executive Officer of Medicare Advantage | $550.00K | – | $904.63K | $13.54K | $1.47M | -69% |
| Conrad Wai Chief Executive Officer of Counterpart Health | $495.00K | – | $704.46K | $12.48K | $1.21M | -73% |
| Brady Priest Chief Executive Officer of Clover Care Services | $495.00K | – | $704.46K | – | $1.20M | -73% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
SPAC offering
- Type
- SPAC (blank check) IPO of units
- Final prospectus filed
- Apr 23, 2020
- Offer price
- $10.00
- Securities offered
- 72,000,000
- Gross proceeds
- $720.00M
- Exchange
- NYSE
- First trading day
- Jun 12, 2020
- First-day close
- $10.20+2.0%
- Lock-up ends (est.)
- Dec 9, 2020
“Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-third of one redeemable warrant.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“At December 31, 2025, we had 724 employees with approximately 93% in the U.S.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?